Epsilon M&A Deal Report - Laboratoires Majorelle
Transaction Multiples for the Valuation of Private Companies

Private Group led by EW Healthcare Partners > Laboratoires Majorelle
Announced Date : 30 April 2021
Type : MBO (Management Buy Out)
Deal Value : Yes
Acquirer : Private Group led by EW Healthcare Partners
Target Laboratoires Majorelle
Target Country France
Sector of activity : Health, Pharmaceuticals & Biotechnology
> Founded in 2012 by Mehdi El Glaoui, Laboratoires Majorelle is a French specialty pharma company focused on prescription and OTC products in women’s health and urology that offer health solutions for men and women ...

Transaction multiples available
EV/Sales | EV/Gross Profit | EV/EBITDA | EV/EBIT | Eq/PBT | P/E | Price to Book | |
---|---|---|---|---|---|---|---|
Historic | |||||||
Current |
: Multiple available
n.s : Multiple calculated, but not significant
Rating *
Source: Epsilon Research / EMAT

Comparable Transactions
Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226
Example of comparable transactions on EMAT (same sub-sector):
Date | Acquirer | Target | Country | Multiples | See details |
---|---|---|---|---|---|
18/06/2021 | Ethypharm | Altan Pharma | Ireland | 0 | |
25/11/2021 | Medios | NewCo Pharma Group | Germany | 0 |
Source: Epsilon Research / EMAT
This report is accessible on EMAT, the reference database for private company acquisition multiples
Example of EMAT Report : click here
View Complete ReportEpsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.
Sectors covered by our analysts
Studies & indices published by Epsilon Research Register to receive (free) publications updates
Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.
Subscribe to EMAT database